Com. v. Tarapchak, S.

Superior Court of Pennsylvania·Decided June 23, 2020·No. 281 MDA 2018·Unpublished

Opinion

J-S17021-20

NON-PRECEDENTIAL DECISION - SEE SUPERIOR COURT I.O.P. 65.37

COMMONWEALTH OF PENNSYLVANIA IN THE SUPERIOR COURT OF PENNSYLVANIA

Appellee

v.

STEPHANIE TARAPCHAK Appellant No. 281 MDA 2018

Appeal from the Judgment of Sentence Entered March 10, 2016 In the Court of Common Pleas of Lackawanna County Criminal Division at No.: CP-35-CR-0000550-2014

BEFORE: PANELLA, P.J., STABILE, J., and FORD ELLIOTT, P.J.E. MEMORANDUM BY STABILE, J.: FILED JUNE 23, 2020 Appellant Stephanie Tarapchak appeals nunc pro tunc from the March 10, 2016 judgment of sentence entered in the Court of Common Pleas of Lackawanna County (“trial court”), following her jury convictions for insurance fraud, theft by deception, corrupt organizations, perjury, endangering the welfare of children (“EWOC”), drug delivery resulting in death, distributing prescription to drug dependent person, and refusal or failure to keep records.1 Upon review, we affirm.

The facts and procedural history of this case are undisputed.2 Appellant

operated a small internal medicine practice in Ashland, Pennsylvania. She

118 Pa.C.S.A. §§ 4117(a)(2), 3922(a)(1), 911(b)(2), 4902(a), 4304(a)(1), 2506(a), and 35 P.S. § 780-113(a)(13), (21), respectively. 2Unless otherwise specified, these facts come from the trial court’s July 17, 2019 opinion. See Trial Court Opinion, 7/17/19, at 3-6, 27-30, 42-43, 51- 53.

J-S17021-20

became the focus of an extensive narcotics and drug diversion investigation, which led to an audit of her DEA, license, including prescription orders, practices, and dispensation in January 2008 through February 2012, spanning three Pennsylvania counties, Lackawanna, Luzerne, and Schuylkill. Concomitantly, Appellant prescribed and dispensed excessive amounts of narcotics to her paramour, Delton Bolton, as well as her minor child, F.T., whereby Appellant became engaged in a hostile custody dispute with her ex- husband, Alex Tarapchak. Additionally, Appellant was investigated in connection with the fatal drug overdose of Thomas Kromer (the “victim”). On April 7, 2014, the Office of the Attorney General charged Appellant with, inter alia, the above-mentioned offenses.

Subsequently, on September 21, 2015, Appellant proceeded to a two-

week jury trial on all of the above-cited criminal offenses. During trial, the Commonwealth presented thirty-four witnesses and admitted a voluminous amount of exhibits. With respect to the victim’s death, the Commonwealth offered the testimony of six witnesses.

First, several witnesses including Deputy Coroner, David Truskowsky, pharmacy manager Scott Rishel, and pain management expert, Dr. Stephen Thomas testified that Appellant prescribed Oxycodone to the victim on June 6, 2011. Second, Mr. Rishel, and Dr. Thomas testified that Appellant prescribed an increased dosage and prescription, which was not in good faith or in accordance with treatment principles accepted by a responsible segment of the medical profession in violation of the Controlled Substance, Drug,

J-S17021-20

Device, and Cosmetic Act. Specifically, Dr. Thomas testified that Appellant failed to comply with the minimal activities outlined by the Pennsylvania Code for prescribing controlled substances. He noted that Appellant failed to document any medical decision making regarding the victim throughout his seven years as her a patient. Dr. Thomas testified that despite Appellant’s recognition of the victim’s apparent physical susceptibility as an individual, and apparent misuse/abuse of his opioid prescription, Appellant enhanced the toxicity of his opioids and did nothing to minimize the fatal effects. Mr. Rishel testified that the victim’s May 19, 2011 Oxycodone prescription should not have necessitated a re-fill prior to June 14, 2011. He recalled that on June 6, 2011, Appellant prescribed an increased dosage and a different medication so as to enable the victim to re-fill his prescription early, and evade insurance restrictions. He verified that if the victim attempted to re-fill the May 19, 2011 Oxycodone prescription on June 6, 2011, his insurance would have rejected payment. Importantly, Mr. Rishel explained that if a person seeks to re-fill a prescription earlier than their supply expiration, then the person must be ingesting the prescription above the therapeutic range.

Third, forensic pathologist, Dr. Richard Bindie, and pain management expert, Dr. Thomas, testified that the victim died as a result of using the June 6, 2011 Oxycodone prescription. Dr. Bindle testified within a reasonable degree of medical certainty that the combined adverse effects of the multiple drugs in the victim’s system induced depressed respiration and arrhythmia. Dr. Thomas testified within a reasonable degree of medical certainty that the

J-S17021-20

normal therapeutic concentration of Oxycodone is less than 100 nanograms per ML and death has been known to occur in susceptible individuals at a level greater than 200 nanograms ML. In this case, Dr. Thomas noted that the victim’s urine concentration reflected Oxycodone at 300 nanograms ML, the highest concentration of any controlled substance within his system at death. Similar to Dr. Bindie, Dr. Thomas confirmed that the Alprazolam within the therapeutic range and the Oxycodone in the toxic range acted synergistically to cause respiratory depression and led to the victim’s death.

Finally, Tracy and David Kuczynski testified that the victim appeared overmedicated and disheveled. Mrs. Kuczynski noted that Appellant failed to provide the victim with instructions or safety mechanisms to prevent abuse and ensure that the victim ingested his prescriptions within the therapeutic range. Mr. Kuczynski confirmed that Appellant hardly ever examined or evaluated the victim prior to filling his prescriptions. He also confirmed that Mr. Kromer re-filled his prescriptions at least seven to ten days earlier than his supply expiration. Mr. Rishel corroborated that the victim’s May 19, 2011 Oxycodone prescription should have lasted until June 14, 2019. Instead, Mr. Rishel recalled that Appellant increased the dosage of the victim’s prior prescription and changed the medication to Oxycodone without Tylenol. He explained Appellant’s modification enabled an early re-fill, evaded insurance restrictions, and represented an increase three times the strength of his previous prescription.

J-S17021-20

Dr. Bindie opined that a patient like the victim, who is predisposed to arrhythmia and is prescribed opiates will experience adverse effects that could increase blood pressure or decrease oxygen and lead to cardiac arrest. He testified that an individual will die from arrhythmia produced by the combination of all the drugs that were present in the victim’s urine concentration at death. Lastly, Dr. Thomas testified that the victim lacked a medical record, lacked regular visitation or examination, yet he obtained prescriptions from Appellant at an accelerating pace. He observed that Appellant enabled the victim, a susceptible individual to misuse/abuse his prescriptions at a continuing and accelerated rate. Dr. Thomas concluded that Appellant prescribed a toxic dosage of Oxycodone to the victim for an underlying headache without any documented medical rationale in order to bypass the victim’s insurance safeguards. Dr. Thomas found that Appellant’s actions were anything but accidental and showed no consideration for the consequences of her increase to the victim, an individual she knew susceptible to psychiatric illness and arrhythmia consumed his opioids in a haphazard and reckless manner.

The Commonwealth also presented evidence demonstrating that Appellant owned the internal medicine practice in Ashland. Appellant exhibited control of the distribution of narcotics to individuals in Ashland through her internal medicine practice and fraudulently billed insurance companies.

J-S17021-20

Free access — add to your briefcase to read the full text and ask questions with AI

Com. v. Tarapchak, S., (Pa. Ct. App. 2020).

Com. v. Tarapchak, S. (Com. v. Tarapchak, S.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Commonwealth v. Hudson
414 A.2d 1381 (Supreme Court of Pennsylvania, 1980)
Commonwealth v. Cousar
928 A.2d 1025 (Supreme Court of Pennsylvania, 2007)
Commonwealth v. Nunn
947 A.2d 756 (Superior Court of Pennsylvania, 2008)
Commonwealth v. Moury
992 A.2d 162 (Superior Court of Pennsylvania, 2010)
Commonwealth v. Tedford
960 A.2d 1 (Supreme Court of Pennsylvania, 2008)
Commonwealth v. Baumhammers
960 A.2d 59 (Supreme Court of Pennsylvania, 2008)
Commonwealth v. Pressley
887 A.2d 220 (Supreme Court of Pennsylvania, 2005)
Commonwealth v. May
887 A.2d 750 (Supreme Court of Pennsylvania, 2005)
Commonwealth v. Brown
359 A.2d 393 (Supreme Court of Pennsylvania, 1976)
Commonwealth v. Dillon
925 A.2d 131 (Supreme Court of Pennsylvania, 2007)
Commonwealth v. Newman
598 A.2d 275 (Supreme Court of Pennsylvania, 1991)
Commonwealth v. Lewis
598 A.2d 975 (Supreme Court of Pennsylvania, 1991)
Commonwealth v. Ludwig
874 A.2d 623 (Supreme Court of Pennsylvania, 2005)
Commonwealth v. Drumheller
808 A.2d 893 (Supreme Court of Pennsylvania, 2002)
Commonwealth v. Bowser
624 A.2d 125 (Superior Court of Pennsylvania, 1993)
Commonwealth v. Long
624 A.2d 200 (Superior Court of Pennsylvania, 1993)
Commonwealth v. Bradfield
508 A.2d 568 (Supreme Court of Pennsylvania, 1986)
Commonwealth v. Williams
936 A.2d 12 (Supreme Court of Pennsylvania, 2007)
Commonwealth v. Possinger
399 A.2d 1077 (Superior Court of Pennsylvania, 1979)
Commonwealth v. Howard
645 A.2d 1300 (Supreme Court of Pennsylvania, 1994)